Vicarious Surgical Raises An Additional $13.2 Mil in Capital

Vicarious Surgical reports funding was led by Philip Liang of E15 Capital.

Vicarious Surgical added Philip Liang and Ric Fulop to their Board of Directors.

“As we approach clinical use with our first product, I am thrilled to bring on Phil, E15 Capital, and the experience of their team,” said Adam Sachs, CEO of Vicarious Surgical. “Adding both the capital and E15’s experience in this industry will be invaluable to our success. This is a great milestone and a strong start to the next phase of our growth as a company.”

In addition to E15 Capital, the new round of funding includes investment from existing investors Bill Gates, Khosla Ventures, Innovation Endeavors, and AME Cloud Ventures. Vicarious Surgical plans use the proceeds to further develop its revolutionary new surgical robotics platform.

“We couldn’t be more excited to join Adam and the Vicarious Surgical team in their mission to offer high-quality surgical care across the world,” said Phillip Liang, Managing Director of E15 Capital. “I’ve been incredibly impressed with the progress the Vicarious Surgical team has made. As an investor in surgical robotics, this is the type of company and founder you hope to find. I am excited to bring our industry experience to the existing team and to drive this company towards helping patients, surgeons, and hospitals across the world.”

Ric Fulop is the founding CEO of Desktop Metal and brings his experience building two unicorn startups to the Vicarious Surgical team as a member of the Board of Directors. “I’m proud to be part of such an incredible team, and excited to help their mission to improve patient care, surgeon experience, and reduce cost from the healthcare system.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”